Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

von Hippel–Lindau Methylation Status in Patients with Multiple Myeloma: A Potential Predictive Factor for the Development of Bone Disease

1 Jun 2009

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Bone health and treatments
Share to Cancer, Hypoxia, and Metabolism
Share to Medical Imaging and Pathology Studies

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 19525194
DOI: 10.3816/clm.2009.n.047

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

von Hippel–Lindau Methylation Status in Patients with Multiple Myeloma: A Potential Predictive Factor for the Development of Bone DiseasePMID 19525194Read ↗

Multiple myeloma in the marrow: pathogenesis and treatments.Semantic proximity Read ↗

Molecular pathogenesis of multiple myeloma and its premalignant precursorSemantic proximity Read ↗

Investigating the Interplay between Myeloma Cells and Bone Marrow Stromal Cells in the Development of Drug Resistance: Dissecting the Role of Epigenetic ModificationsSemantic proximity Read ↗

Multiple Myeloma Bone Disease: Implication of MicroRNAs in Its Molecular BackgroundSemantic proximity Read ↗

Genetic factors influencing the risk of multiple myeloma bone disease.Semantic proximity Read ↗

Targeting aberrant DNA methylation in mesenchymal stromal cells as a treatment for myeloma bone diseaseSemantic proximity Read ↗

Targeting aberrant DNA methylation in mesenchymal stromal cells as a treatment for myeloma bone diseaseSemantic proximity Read ↗

Epigenetic Crosstalk between Malignant Plasma Cells and the Tumour Microenvironment in Multiple MyelomaSemantic proximity Read ↗

Aberrant Levels of miRNAs in Bone Marrow Microenvironment and Peripheral Blood of Myeloma Patients and Disease ProgressionSemantic proximity Read ↗

Epigenetic regulatory mutations and epigenetic therapy for multiple myeloma.Semantic proximity Read ↗

Genetic determinants of multiple myeloma risk within the Wnt/beta-catenin signaling pathway.Semantic proximity Read ↗

Aberrant DNA methylation in multiple myeloma: A major obstacle or an opportunity?Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.